15 Ulcerative Colitis Clinical Trials in La Jolla, CA (2026)

Q: How do I join a clinical trial in La Jolla?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the La Jolla research site will contact you.

Recruiting Ulcerative Colitis Studies in La Jolla

NCT00221897Recruiting

Diagnostic Innovations in Glaucoma Study

The overarching goal of our research study is to evaluate changes in visual function and optic nerve topography (the structure of the back of the eye) in patients with glaucoma (increased susceptibili...

La Jolla, CA3,000 participantsUniversity of California, San Diego

View Study Details

NCT05489705Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructi...

La Jolla, CA1,700 participantsBristol-Myers Squibb

View Study Details

NCT05219110Recruiting

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E...

La Jolla, CANA1,040 participantsUniversity of Calgary

View Study Details

NCT04333537Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavi...

La Jolla, CAPHASE2686 participantsNRG Oncology

View Study Details

NCT07012395Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficac...

La Jolla, CAPHASE2645 participantsSpyre Therapeutics, Inc.

View Study Details

NCT06398626Recruiting

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to s...

La Jolla, CA300 participantsPfizer

View Study Details

NCT05230173Recruiting

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, v...

La Jolla, CANA250 participantsUniversity of California, San Diego

View Study Details

NCT05237505Recruiting

The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)

Major progress has been made in the area of cardiovascular disease, but we believe that further progress will involve mechanistically addressing underlying respiratory causes including chronic obstruc...

La Jolla, CAPHASE2240 participantsUniversity of California, San Diego

View Study Details

NCT06029972Recruiting

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will comp...

La Jolla, CAPHASE2176 participantsGilead Sciences

View Study Details

NCT07023614Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard...

La Jolla, CAPHASE2165 participantsImbria Pharmaceuticals, Inc.

View Study Details

NCT05804084Recruiting

Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea

Obstructive sleep apnea (OSA) is a severe type of snoring causing people to choke in their sleep. It affects millions of Americans, causing many health problems. For example, patients with OSA often f...

La Jolla, CAPHASE260 participantsUniversity of California, San Diego

View Study Details

NCT06790602Recruiting

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

This is a Phase 2 trial evaluating the combination of cemiplimab with the standard of care chemotherapy agent gemcitabine for the treatment of patients with metastatic pancreatic ductal adenocarcinoma...

La Jolla, CAPHASE243 participantsUniversity of California, San Diego

View Study Details

NCT04721873Recruiting

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Approximately 20-40% of patients with ulcerative colitis (UC) are obese. The investigators have demonstrated that obesity adversely impacts disease course in patients with UC, leading to higher risk o...

La Jolla, CAPHASE240 participantsUniversity of California, San Diego

View Study Details

NCT06639724Recruiting

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

This is a Phase 1b trial evaluating the combination of Fostamatinib, a Syk kinase inhibitor currently FDA-approved for chronic idiopathic thrombocytopenia purpura (ITP), with the standard of care chem...

La Jolla, CAPHASE136 participantsUniversity of California, San Diego

View Study Details

NCT07638943Recruiting

Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses

The purpose of this study is to determine the comfort and vision of DAILIES TOTAL1 Multifocal contact lenses in a population of satisfied INFUSE One-Day Multifocal contact lens wearers...

La Jolla, CANA30 participantsGordon Schanzlin New Vision

View Study Details

About Ulcerative Colitis Clinical Trials in La Jolla

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 15 ulcerative colitis clinical trials recruiting participants in La Jolla, CA. These studies are seeking a combined 8,411 participants. Research is being sponsored by University of California, San Diego, Bristol-Myers Squibb, University of Calgary and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in La Jolla — FAQ

Are there ulcerative colitis clinical trials in La Jolla?

Yes, there are 15 ulcerative colitis clinical trials currently recruiting in La Jolla, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in La Jolla?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Jolla research site will contact you about next steps.

Are clinical trials in La Jolla free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Jolla studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 15 active trials in La Jolla are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 18, 2026 from ClinicalTrials.gov